In June of 2013, the AVMA implemented three new compounding policies to advocate for members. We continue to monitor for ways to advocate, given critical needs for drug availability in veterinary medicine. We know the federal government continues to eye compounding as a high-priority topic, so our communication activities on compounding continue to grow.
The most recent communications we’ve undertaken include a letter to FDA, underscoring, in part, how our new policies provide some workable ways forward on compounding, especially for non-food animals. The AVMA’s Council on Biologic and Therapeutic Agents and its Clinical Practitioners Advisory Committee also recently hosted a webinar for members on compounding practices and current rules, and we released a short Compounding 101 video this past fall. We continue to monitor for opportunities to communicate our policies on behalf of members, as well as to post educational materials on compounding for members. As always, we appreciate input from members on these and other relevant drug issues. In the meantime, our compounding webpage includes helpful resources such as a compounding brochure, AVMA policies, and “Dear Veterinarian” letters from FDA about the benefits of using FDA-approved drugs.